IRF7 Antikörper (AA 1-150)
Kurzübersicht für IRF7 Antikörper (AA 1-150) (ABIN306441)
Target
Alle IRF7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1-150
-
Verwendungszweck
- Human IRF7 antibody
-
Aufreinigung
- Purified
-
Immunogen
- Recombinant human IRF-7 (1-150aa) purified from E. coli
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
- Recommended dilution 1:1000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing cycles
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
-
-
- IRF7 (Interferon Regulatory Factor 7 (IRF7))
-
Andere Bezeichnung
- IRF7
-
Hintergrund
- Interferon regulatory factor (IRF) 7 is a member of the interferon regulatory transcription factor family. IRF7 plays an essential role in virus-activated transcription of type I interferon alpha genes. Inducible expression of IRF7 is largely restricted to lymphoid tissue. Multiple IRF7 transcript variants have been identified, although the functional consequences of these have not yet been established.
-
NCBI Accession
- NP_001563
-
Pathways
- TLR Signalweg, Activation of Innate immune Response, Hepatitis C, Toll-Like Receptors Cascades, Autophagie
Target
-